2021
DOI: 10.1111/ajt.16532
|View full text |Cite
|
Sign up to set email alerts
|

Donor to recipient transmission of SARS-CoV-2 by lung transplantation despite negative donor upper respiratory tract testing

Abstract: We describe a case of proven transmission of SARS‐CoV‐2 from lung donor to recipient. The donor had no clinical history or findings suggestive of infection with SARS‐CoV‐2 and tested negative by reverse transcriptase polymerase chain reaction (RT‐PCR) on a nasopharyngeal (NP) swab obtained within 48 h of procurement. Lower respiratory tract testing was not performed. The recipient developed fever, hypotension, and pulmonary infiltrates on posttransplant day (PTD) 3, and RT‐PCR testing for SARS‐CoV‐2 on an NP s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
152
0
2

Year Published

2021
2021
2023
2023

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 130 publications
(155 citation statements)
references
References 14 publications
1
152
0
2
Order By: Relevance
“…A case of donor-derived SARS-CoV-2 transmission has been described in a lung transplant recipient whose lung donor tested negative for SARS-CoV-2 by nasopharyngeal PCR but was retrospectively found to be positive on bronchoalveolar lavage fluid obtained at procurement. 17 Currently, there are no clinical data that accurately define the risk of transmission of SARS-CoV-2 with liver transplant. Several small studies do provide insight to SARS-CoV-2 viremia and organotropism beyond the respiratory tract.…”
Section: Discussionmentioning
confidence: 99%
“…A case of donor-derived SARS-CoV-2 transmission has been described in a lung transplant recipient whose lung donor tested negative for SARS-CoV-2 by nasopharyngeal PCR but was retrospectively found to be positive on bronchoalveolar lavage fluid obtained at procurement. 17 Currently, there are no clinical data that accurately define the risk of transmission of SARS-CoV-2 with liver transplant. Several small studies do provide insight to SARS-CoV-2 viremia and organotropism beyond the respiratory tract.…”
Section: Discussionmentioning
confidence: 99%
“…International scientific societies advice against the use of organs from deceased donors tested positive for SARS-CoV-2, particularly for lung donors (81-83). However, a case report describing a proven transmission of SARS-CoV-2 from a lung donor, who tested negative by RT-PCR on a nasopharyngeal swab but positive on bronchoalveolar lavage fluid when subsequently tested, supports universal SARS-CoV-2 testing in the lower respiratory tract before lung donation (84).…”
Section: Human Coronavirusesmentioning
confidence: 93%
“…Recently, a case of SARS-CoV-2 transmission during the lung transplantation has been reported despite a negative result from the pre-implantation NP swab of the donor. The assessment of LRT specimens from potential lung donors should be therefore preferred for the virological screening prior to the transplant [11]. Similar investigations will be recommended also for other organ transplants because the wide tropism of SARS-CoV-2 that is detected in multiple sample types (plasma, rectal swabs, stool, urine, kidney and lung tissues) [12].…”
Section: Discussionmentioning
confidence: 99%